As of January 22, 2025, Krystal Biotech (KRYS) has a market cap of $4.41 billion USD. According to our data, Krystal Biotech is ranked No.2879 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $4.41 B |
-2.22%
|
Dec 31, 2024 | $4.51 B |
26.28%
|
Dec 29, 2023 | $3.57 B |
56.60%
|
Dec 30, 2022 | $2.28 B |
13.25%
|
Dec 31, 2021 | $2.01 B |
16.58%
|
Dec 31, 2020 | $1.73 B |
8.34%
|
Dec 31, 2019 | $1.59 B |
166.51%
|
Dec 31, 2018 | $0.60 B |
97.53%
|
Dec 29, 2017 | $0.30 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Sarepta Therapeutics
SRPT
|
$11.08 B |
-0.000 M
|
USA
|
Boundless Bio
BOLD
|
$58.38 M |
0.000 M
|
USA
|
bluebird bio
BLUE
|
$77.02 M |
0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.37 B |
0.000 M
|
USA
|
Editas Medicine
EDIT
|
$0.10 B |
-0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.13 B |
-0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.03 B |
0.000 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.70 B |
-0.001 M
|
USA
|
Rocket Pharmaceuticals
RCKT
|
$1.08 B |
-0.000 M
|
USA
|
MaxCyte
MXCT
|
$0.53 B |
-0.000 M
|
USA
|
Cellectis
CLLS
|
$0.16 B |
4.583 M
|
France
|
Solid Biosciences
SLDB
|
$0.13 B |
-0.000 M
|
USA
|
Genprex
GNPX
|
$6.13 M |
0.000 M
|
USA
|
Market Cap | = | KRYS Stock Price | * | KRYS Shares Outstanding |
= | $153.18 | * | 28.76 M | |
= | $4.41 B |